After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Tourmaline Bio Inc is $457.71M. A total of 0.6 million shares were traded on the day, compared to an average of 347.56K shares.
In the most recent transaction, Kulkarni Sandeep Chidambar bought 1,779 shares of TRML for 14.85 per share on Aug 21 ’24. After the transaction, the CEO now owns 7,000 company shares. In a previous transaction on Aug 16 ’24, Kulkarni Sandeep Chidambar bought 5,221 shares at 13.79 per share. TRML shares that CEO owns now total 5,221.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, TRML has a high of $29.79 and a low of $11.56.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. TRML’s latest balance sheet shows that the firm has $150.00k in Cash & Short Term Investments as of fiscal 2021. There were $150.00k in debt and $376.00k in liabilities at the time. Its Book Value Per Share was $12.52, while its Total Shareholder’s Equity was -$226.00k.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TRML is Buy with a score of 5.00.
